Date: 2015-10-13
Type of information: Nomination
Compound:
Company: Merck KGaA (Germany)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On October 13, 2015, the Board of Partners of E. Merck KG appointed Stefan Oschmann (58) as new Chairman of the Executive Board and CEO of Merck KGaA. The appointment will take effect with the end of the Annual General Meeting on April 29, 2016. Stefan Oschmann will succeed Karl-Ludwig Kley (64) who will retire after then eight years as head of Merck.
Stefan Oschman has been a member of the Executive Board of Merck since 2011. He was initially in charge of the pharma business before being appointed as Deputy Chairman of the Executive Board and Deputy CEO at the beginning of 2015, responsible for strategy and innovation.
Financial terms:
Latest news:
